Cell of origin determines clinically relevant subtypes of MLL-rearranged AML
2012 · Leukemia · 201 citations
https://doi.org/10.1038/leu.2012.363
M
Matthew C. Stubbs
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
3.0K
Citations
18
h-index
25
i10-index
Matthew C. Stubbs is an academic researcher from Incyte (United States). The author has contributed to research in topics: Protein Degradation and Inhibitors & Acute Myeloid Leukemia Research & Histone Deacetylase Inhibitors Research. The author has an h-index of 18, co-authored 99 publications.
ORCID: 0000-0003-3771-7083Papers by this author
worksHMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression
2022 · Blood · 44 citations
https://doi.org/10.1182/blood.2021013925
A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX)
2024 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-024-67028-3
BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesis
2024 · Blood Neoplasia · 1 citations
https://doi.org/10.1016/j.bneo.2024.100040
Table S2 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25515912.v1
Table S1 from Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
2024 · 0 citations
https://doi.org/10.1158/0008-5472.25515915.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat